Roflumilast Foam .3% Demonstrates Significant, Rapid Improve

Patients with scalp and body psoriasis who used nonsteroidal roflumilast foam .3% once daily experienced significant symptom improvement as early as 2 weeks.

Related Keywords

Melinda Gooderham , Skin Research Centre In Peterborough , Skin Centre For Dermatology , Skin Centre For Dermatology Melinda Gooderham , Drug Administration , Clinical Dermatology , Principal Investigator , Global Assessment , Psoriasis Scalp Severity Index , Psoriasis Area , Severity Index , Psoriasis Symptom , Worst Itch Numeric Rating Scale ,